CCR2 deficiency in monocytes impairs angiogenesis and functional recovery after ischemic stroke in mice

Jordi Pedragosa1,2, Francesc Miró-Mur2,3, Amaia Otxoa-de-Amezaga1,2

  • 1Department of Brain Ischemia and Neurodegeneration, Institut d'Investigacions Biomèdiques de Barcelona (IIBB), Consejo Superior de Investigaciones Científicas (CSIC), Barcelona, Spain.

Insights

CCR2+ monocytes infiltrate the brain after stroke, influencing inflammation and repair. Selective deletion impaired recovery, highlighting their role in functional outcomes and brain healing.

Area of Science:

  • Neuroimmunology
  • Stroke Pathophysiology

Background:

  • Inflammatory monocytes (Ly6C high, CCR2+) infiltrate the brain post-stroke.
  • Their precise roles in stroke pathogenesis and recovery remain incompletely understood.

Purpose of the Study:

  • To investigate the function of CCR2+ monocytes in the ischemic brain.
  • To explore the heterogeneity and reparative potential of these infiltrating monocytes.

Main Methods:

  • Generation of mice with selective CCR2 deletion in monocytes.
  • Analysis of immune cell infiltration, gene expression (pro-inflammatory, M2, angiogenesis), and behavioral performance post-ischemia.
  • Flow cytometry to characterize monocyte phenotypes.

Main Results:

  • CCR2+ monocyte-deficient mice exhibited reduced acute inflammation and delayed inflammatory rebound.
  • These mice showed impaired angiogenesis and worse behavioral outcomes post-stroke.
  • Infiltrating monocytes displayed heterogeneous phenotypes, including Arginase-1+ cells, and expressed mixed pro-inflammatory and pro-reparative genes.

Conclusions:

  • CCR2+ monocytes are crucial for acute post-ischemic inflammation and contribute to functional recovery after stroke.
  • Heterogeneity within CCR2+ monocyte populations suggests distinct subsets with varying roles in repair.
  • Targeting specific monocyte subsets may offer therapeutic strategies for stroke recovery.

Related Concept Videos